Navigation Links
Ca++-Induced G Protein Coupled Receptor (GPCR) Activation Monitored via Aequorin Luminescence in the LMax Microplate Luminometer (MaxLine Application Note #42)

Jinfang Liao, M.D., Ph.D. and Evelyn McGown, Ph.D.
Molecular Devices Corporation, 8/00


INTRODUCTION
The photoprotein aequorin, a bioluminescent protein from the coelentratejellyfish Aequorea victorea, has proven to be highly sensitive to the trace amount of Ca++ in cells. The aequorin complex which contains the 22,000 MW apo-aequorinprotein, molecular oxygen, and the luminophore coelenterazine1,2 emits blue light (469 nm) upon binding calcium ions (Figure 1). The binding of Ca++ to aequorin induces a conformational change resulting in the oxidation ofcoelenterazine through an intramolecular reaction. This bioluminescent processpresents an advantage over Ca++-sensitive fluorescent dyes by being easilytargeted to specific cells and to subcellular compartments with appropriateregulatory elements and peptide signals3. Moreover, the aequorin complex doesnot require light excitation, thus eliminating autofluorescence, photobleachingand biological degradation problems. Its high affinity for Ca++ (Kd = 10 M) makes aequorin a good sensor in the biological range of intracellular Ca++ concentrations. The quick flash luminescence that is produced by aequorin canbe measured easily with the Lmax microplate luminometer equipped withautomated reagent injectors.

In a related previous application note4, we have described how to use Molecular Devices Lmax microplate luminometer to measure luciferase activity. Here, wedemonstrate how to use Lmax to detect receptor-activated Ca++ signals in cellsstably expressing apo-aequorin. In these cell-based assays, we were able toconstruct agonist concentration-response curves for the activation of a Gqprotein-coupled purinergic receptor expressed endogenously in CHO cells. Thus,the Lmax microplate luminometer can be used to study GPCR pharmacology.Furthermore, w
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. A New C-Terminal GST Vector for Protein Production in S. pombe
2. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
3. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
4. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
5. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
6. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
7. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Yeast Protein Production System Features High Yields and One-Step Purification
10. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
11. Expression and Purification of Recombinant Proteins That Have Native Amino Acid Sequence

Post Your Comments:
(Date:11/5/2009)...l/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO...r ended September 30, 2009. The Company,s financia... ,, Third Quarter 2009 ,, The Company repo... the third quarter of 2009 as compared to a net lo...arter of 2008. ,, Net sales were $5.0 million ...
(Date:11/5/2009)...ire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), ...tor-based technologies to discover novel flavor in...upply industries, today provided a corporate updat...rter ended September 30, 2009. Revenues were $4.2...o $4.0 million for the third quarter of 2008, an i...
(Date:11/5/2009)...y firm BioSoteria announced that its Vice Presiden...d Professional in Learning and Performance™ ...aining and Development (ASTD) Certification Instit... of medical communications and health care trainin...t of the company,s online pharmacovigilance curric...
(Date:11/4/2009)...ccine Program must be stopped. Scott Miller and C... to Arms:2009 Edition" and the one-hour telev...Anthrax Vaccine Story" to inform the public a...vernment science turned into for-profit human anth.... It is available for world-wide licensing by mot...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
...ober 6, 2008 at 3:00 p.m. EDT, BROOMFIELD, Colo.,... company developing genetically-targeted therapies...es, today announced that,Richard Brewer, the compa.... Michael Bristow, M.D., ARCA,s chairman and chief...Third Annual JMP Securities Healthcare Focus,Confe...
...erapy in U.S. to be Indicated ...ell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC...ntal,Biologics License Application (sBLA) with the...f Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,conso...iously untreated,patients with follicular non-Hodg...
...No. 40/2008, - To OMX Nordic Exchange Copenhagen ...t of license to Roche Diagnostics for,use of the U...oprietary,LNA(TM) detection technology., Roche Di...alTime ready,qPCR assays with the Universal ProbeL...M) detection technology., "This extension of our ...
Other Biology Technology:ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 2ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 3ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 4ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 5Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 2Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 3
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/5/2009)... been awarded a training grant in the amount of $2...its Integrative Graduation Education and Research ...grant to be awarded to Kent State. The grant, whic...stment Act of 2009, runs through 2014. , The gra...ent aquatic resource sensing (EARS). The purpose o...
(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3
...pert at Johns Hopkins who has spent nearly three d...nfection known as Rocky Mountain spotted fever war...rial disease in Arizona is a growing and dangerous...infectious organisms beyond traditional state boun... England Journal of Medicine, the Hopkins patholog...
...h Institute have found that three bacterial specie... cancer--a discovery the researchers hope will lea...disease. , The findings also open the question of...l role. , The current discovery, reported in the J...that elevated levels of three particular bacteria ...
...nt a great advance for human health. It is based o...NOXIDE system, used in refrigeration towers of fac... be the focus for the proliferation of Legionnaire... team of INASMET-Tecnalia experts designed a refri...olated laboratory (P2 level). A wide range of tria...
Other Biology News:Infectious disease expert warns of spread of Rocky Mountain spotted fever 2Infectious disease expert warns of spread of Rocky Mountain spotted fever 3Forsyth scientists find three bacteria associated with oral cancer 2Forsyth scientists find three bacteria associated with oral cancer 3
...TI-RNase is a protein ribonuclease inhibitor that ...atic RNase A-type enzymes. No inhibition is seen w...is distinct from human placental ribonuclease inhi...h RNase and does not release active RNase in the a...
RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
...e ChIP (Chemical Inkjet Printer) is a revolutionar...Protein Macroarray Analysis, developed in conjunct...ms. The strategy compliments established protocols...eins isoelectric point and apparent molecular weig...
...tural and Recombinant RNasin Ribonuclease Inhibito..., including the inhibition of eukaryotic RNases of...s inhibitory effect by noncovalently binding to RN...of RNasin Ribonuclease Inhibitor to RNase (e.g., R...
Biology Products: